RPG Life Sciences News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of RPG Life Sciences Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: RPG Life Sciences Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news and updates on RPG Life Sciences from all sources in a single place.

RPG Life Sciences Ltd.

10 Feb 2026

1880.00

3.13%

Company Update

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper intimation regarding Special Window for re-lodgement of transfer requests of Physical shares

pdf

RPG Life Sciences Ltd.

30 Jan 2026

1880.00

3.13%

Company Update

RPG Life Sciences Ltd - 532983 - General Updates

BSE India

Intimation of executed share subscription and shareholder''s agreement (SSSHA) and Captive Power Agreement (CPA) for procuring electricity from First Energy 11 Private Limited

pdf

RPG Life Sciences Ltd.

29 Jan 2026

1880.00

3.13%

RPG Life Sciences

Buy: RPG Life Sciences Ltd.

ICICI Direct

About the company- RPG Life Sciences RPGLS (part of RPG Group) is a pharmaceutical company that operates in the domestic and international markets in the branded formulations, global generics and synthetic APIs space. The company...

RPG Life Sciences Ltd. has an average target of 2470.00 from 1 broker.

RPG Life Sciences Ltd.

28 Jan 2026

1880.00

3.13%

Company Update

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication

pdf

RPG Life Sciences Ltd.

28 Jan 2026

1880.00

3.13%

RPG Life Sciences tumbles over 10% as Q3 net profit declines 20% YoY

Business Standard

The scrip declined 10.6 per cent to the day's low of 1,880 on the National Stock Exchange (NSE)

RPG Life Sciences Ltd.'s price crossed below 30Day SMA today

RPG Life Sciences Ltd.

28 Jan 2026

1880.00

3.13%

Investor Presentation

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Intimations of Revised Investor presentation

pdf

RPG Life Sciences Ltd.

28 Jan 2026

1880.00

3.13%

to see Rapid results content

RPG Life Sciences Ltd.

27 Jan 2026

1880.00

3.13%

Investor Presentation

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation in respect to the Board Meeting held on January 27, 2026

pdf

RPG Life Sciences Ltd.

27 Jan 2026

1880.00

3.13%

Company Update

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release in respect to the Board Meeting held on January 27, 2026

pdf

RPG Life Sciences Ltd.

27 Jan 2026

1880.00

3.13%

Result

RPG Life Sciences Ltd - 532983 - Financial Result Quarter Ended On December 31, 2025

BSE India

Financial Result Quarter ended on December 31, 2025

pdf

	Dec 2025	Sep 2025	Dec 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	183.44	186.22	176.02	-1.5%	4.2%
Operating Profit Qtr	39.76	39.03	49.16	1.9%	-19.1%
Net Profit Qtr	22.13	36.85	34.93	-39.9%	-36.6%
Earning Per Share Adjusted latest Qtr	13.38	22.28	21.12	-39.9%	-36.6%

* Standalone data

Detailed Results

Is RPG Life Sciences Ltd. worth buying?

84 Votes:

Buy 72.62%

Sell 17.86%

Hold 9.52%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Not Rated SEE REPORTS >

pdf